Frequenin (Frq) and its mammalian homologue, neuronal calcium sensor 1 (NCS-1), are important calcium-binding proteins which enhance neurotransmitter release and facilitation. Here, we report the discovery of a second Frq-encoding gene (frq2) in Drosophila. The temporal and spatial expression patterns of the two genes are very similar, and the proteins they encode, Frq1 and Frq2, are 95% identical in amino acid sequence. Frq1 is more abundant than Frq2, and is most highly expressed in larva. Loss-of-function phenotypes were studied using dominant negative peptides to prevent Frq target binding, RNAi to reduce gene transcription, or both methods. To discriminate chronic from acute loss-of-function effects, we compared the effects of transgenic expression and forwardfilling the dominant-negative peptide into presynaptic terminals. In both cases, a 70% reduction in quantal content per bouton occurred, demonstrating that this trait does not result from homeostatic adaptations of the synapse during development. The chronic treatment also produced more synaptic boutons from MNSNb ⁄ d-Is motorneurons, but fewer active zones per bouton. By contrast, excess-of-function conditions yielded a 1.4-to 2-fold increase in quantal content and fewer boutons in the same motorneuron. These synaptic effects resulted in behavioural changes in the Buridan locomotion assay, showing that walking speed is dependent on Frq activity in the nervous system. All the effects were identical for both Frqs, and consistent with excess-and loss-of-function genotypes. We conclude that Frqs have two distinct functions: one in neurotransmission, regulating the probability of release per synapse, and another in axonal growth and bouton formation.
Introduction
Frequenin (Frq) is a Ca 2+ -binding protein first identified in Drosophila melanogaster (Pongs et al., 1993) . Homologs have been identified from yeast to vertebrates, including the mammalian neuronal calcium sensor 1 (NCS-1); (Olafsson et al., 1995; McFerran et al., 1998; Chen et al., 2001 ). Several interactions, described in mammals, correlate Frq ⁄ NCS-1 with the regulation of normal and diseased brain function (see Burgoyne et al., 2004 for a review). Thus, the interaction of Frq with IL1 receptor accessory protein-like, a protein involved in X-linked mental retardation, suggests a link between the disease and the Ca 2+ -dependent regulation of exocytosis. Also, Frq interacts with the dopamine D2 receptor in human HEK293 cells (Kabbani et al., 2002) , regulating its activity, and both proteins are localized in the prefrontal cortex of primates (Negyessy & Goldman-Rakic, 2005) , indicating a role of Frq in the modulation of dopaminergic signalling pathways. Up-regulation of NCS-1 has been reported in schizophrenic and bipolar patients (Koh et al., 2003) .Members of this protein family bind Ca 2+ at their EF-hand domains and regulate many cellular signalling pathways (Burgoyne & Weiss, 2001) . In various species, major physiological phenotypes have been ascribed to Frq in neurons, including enhancement of short-term facilitation and long-term potentiation (Genin et al., 2001; Sippy et al., 2003; Brackmann et al., 2004) , basal release of neurotransmitter (Olafsson et al., 1995) when Frq is overexpressed, and learning impairment when Frq is depleted (Gomez et al., 2001 ). In Drosophila, initial studies indicated that overexpression of Frq enhances short-term facilitation following paired-pulse stimulation and brief trains of high frequency stimulation, but has no effect on basal levels of evoked neurotransmitter release or on spontaneous release (Mallart et al., 1991; Pongs et al., 1993; Rivosecchi et al., 1994) . However, these experiments were caried out in solutions with very low external Ca 2+ concentrations ([Ca 2+ ] e ) of 0.12-0.2 mm; the normal [Ca 2+ ] e in haemolymph is 1-2 mm . Alterations in Frq levels could produce different effects on evoked neurotransmitter release at higher [Ca 2+ ] e . In addition, a developmental effect of Frq on nerve terminal morphology is evident: larval neuromuscular junctions are reduced in Frq overexpressers (Angaut-Petit et al., 1998) . However, it is not known whether this altered morphology is causally linked to changes in neurotransmission.
Evidence for the role of NCS-1 ⁄ Frq in synaptic transmission is based mainly on its overexpression (Zhao et al., 2001; Koizumi et al., 2002; Pan et al., 2002; Scalettar et al., 2002; Taverna et al., 2002; Rajebhosale et al., 2003; Sippy et al., 2003) . Loss-of-function (more properly 'target inactivation') studies are based on a dominant negative C-terminal peptide of NCS-1 that abolishes activity-dependent facilitation of calcium currents in the mammalian calyx of Held (Tsujimoto et al., 2002) . However, concomitant effects of the peptide on synaptic transmission are unknown. In fact, the physiological consequences of loss of Frq functionality have yet to be determined. Recently, two NCS-1 genes have been found in zebrafish (Danio rerio); whether they have separate functional or developmental roles is currently unknown (Blasiole et al., 2005) . In the present study, we describe a second frequenin gene (frq2) in Drosophila which encodes a protein 95% identical to Frq1. This raises the same question about possible differences in function or development for the two Frq proteins.The present study addresses three unresolved questions about the functions of Frq in Drosophila. (i) Do the two Frq-encoding genes in Drosophila have distinct temporal profiles and ⁄ or functions? (ii) Do both Frq1 and Frq2 affect spontaneous or evoked neurotransmitter release? (iii) Is the effect of Frq on nerve terminal morphology related to its effect on synaptic transmission? We used the Gal4 ⁄ UAS system to overexpress Frq1 and ⁄ or Frq2, and RNA interference to reduce protein levels. Also, to further study loss-of-function effects, we introduced a C-terminal peptide that disrupts the interactions of Frq with its targets. The peptide was expressed transgenically or forwardfilled to presynaptic terminals so that we could distinguish between chronic and acute loss-of-function effects. We found that the two Drosophila Frqs have a dual role: they regulate quantal release per synapse, and they modify the formation of synaptic boutons. These synaptic effects also have behavioural consequences in an adult locomotion assay.
Materials and Methods

Fly stocks
Wandering third-instar larvae were used for all experiments unless otherwise indicated. Canton-S (+) flies were used as wild-type. The rearrangement T(X;Y)V7 (Mallart et al., 1991) causes Frq2 to be overexpressed, and is referred to here as V7. The Gal4 ⁄ UAS system (Brand & Perrimon, 1993) was used to overexpress full-length Frq1 and ⁄ or Frq2 in the nervous system, and the resulting phenotypes were studied. The same method was used for conditionally expressing C-terminal dominant negative peptides, alone or in combination with RNA interference, to obtain loss-of-function conditions for Frq1 and Frq2. Lines D42-Gal4 and elav-Gal4 (Lin & Goodman, 1994; Parkes et al., 1998) were used to drive the expression of UAS constructs selectively in motor neurons and throughout the nervous system, respectively. As an ubiquitous driver, we used tubulin-Gal4-LL7 (tubGal4). Several transgenic lines were obtained for each Frq, DN-Frq or RNAi construct (see below). These are referred to here by code numbers (e.g. UAS-Frq1-64C is referred to as Frq1-64C). For brevity, the symbol (›) indicates excess of function in the figures. The corresponding genotypes are described in each figure legend. Phenotypes among different transgenic lines for any given construct were not significantly different. Most fly lines were obtained from the Drosophila stock centre in Bloomington (Fly Base http://flybase.bio.indiana.edu).
Generation of UAS-frq constructs and transgenic lines
P-UAS-frq1
The open reading fram (ORF) of the frq1 gene was amplified using the forward primer 5¢-ATCGAATTCGAGCCACAACAAGAGAAC-3¢ and the reverse primer 5¢-GGAAGATCTTTGTTTAAGCGGG-TTTCG-3¢ in a, RT-PCR assay using adult Canton-S RNA as template. The product was cloned into Eco-RI and Sma-I restriction sites of the pBluescript KSII+, modified with new Not-I and Xho-I sites at the beginning of the polylinker, pBS(Not) vector. The frq1 ORF fragment was later transferred from pBS(Not-I) to pUASt vector using the Not-I restriction site.
P-UAS-frq2
The ORF of the frq2 gene was amplified using the forward primer 5¢-CTTGCAGATCGAACTGAGACC-3¢ and the reverse primer 5¢-CGGCTAATCACCACCTAAACTT-3¢, in an RT-PCR assay from adult CS RNA. The produced amplicon was cloned into pBluescript KSII+, digested with Sma-I and transferred into pUASt vector using the XhoI ⁄ XbaI restriction sites.
P-UAS-RNAi
We used a genomic-cDNA hybrid construct for RNA interference; this design has been proven to effectively silence target genes in Drosophila (Kalidas & Smith, 2002; Winther et al., 2006) . The amplified ORF of frq1 gene was cloned, using the same primers as for pUAS-cDNAfrq1 construct, into pGEMT-easy vector (Promega, Madison, USA). Forward primer 5¢-CACAGAGAAAGAAAT-ACGTCAATGG-3¢ and reverse primer 5¢-GAAGATCTCTGC-TGTCCCTGTTT-3¢ were used for a 2.3-kb genomic fragment amplification using DS07826 STS genomic clone as template. This amplicon contains the exons 3, 4, 5, 6 and 7 with their respective introns and the beginning of exon 8 of the frq1 gene. This fragment was cloned into pGEMT-easy. The BglII ⁄ SpeI fragment of the pGEM-T-easy-frq1 construct contains the ATG and 450 nucleotides downstream of the start codon of the frq1 cDNA. It was introduced in a reverse orientation at the BglII restriction site present in the 8th exon of the 2.5-kb genomic fragment. This yielded a pGEM-T-easy construct containing a 5-kb genomic)400-bp reverse cDNA which was transferred from pGEM to the pUASt vector, cutting at the Not-I restriction site (Supplementary material, Fig. S1 ).
P-UAS-DN-Frq1
We cloned the 261-bp Bgl-II ⁄ Xba-I fragment from the pUAS-frq1 construct into pUASt. This fragment encodes the last 33 amino acids (aa) of the Frq1 COOH-terminus with the sequence MDKNHDGKLTLEEFREGSKADPRIVQALSLGGG.
P-UAS-DN-Frq2
From the pUAS-frq2 construct, digestion with Bgl-II ⁄ Xba-I restriction enzymes gave a 133-bp fragment which we cloned into the pUASt vector. This fragment encodes the 33 aa of the Frq2 COOH-terminal, sequenced as: MDKNHDDRLTLEEFREGSKADPRIVQALSLGGD.
All these constructs were sequenced and checked in the databases using the BLAST program of the NCBI site. Germ-line transformations of these constructs were performed in y w embryos by standard procedures .
Quantitative RT-PCR
About 20 individuals of each genotype were used per RNA extraction with TRIZOL reagent (Invitrogen, Barcelona, Spain). A total of 2 lg of RNA was reverse-transcribed into cDNA using the First Strand kit (GE Healthcare Bioscience, Madrid, Spain) and 0.2 lg of oligo per reaction, according to the manufacturer's instructions. As a normalizing internal control, we used the 140-kDa RNApol-II subunitencoding gene (Falkenburg et al., 1987) . Exon-specific primers for the three genes tested (frq1, frq2 and RNApolII) were designed from databank sequences. Forward primer 5¢-CGATCTACCAGATG-GTGGGACAG-3¢ overlapping exons 7 and 8 of the frq1
Frequenins on neurotransmission 2429 mRNA gene and reverse primer 5¢-GAACTATACGTGGATCAGC-TTTACTACCC-3¢ in exon 8 were used to amplify a 159-bp fragment of the frq1 mRNA. Forward primer 5¢-CGAATTTCCTTTTCAGT-GAAGTATGTG-3¢ and reverse primer 5¢-CCGCCAAAGAGG-AAAAGTAGACG-3¢, located in exons 2 and 3, respectively, were used to amplify a 138 bp fragment of the mRNA of frq2 gene. Forward primer 5¢-GCGTAACACGTATCAAAGCCCTATGGTAA-GC-3¢ overlapping exon 2 and exon 3 of the RpII140 gene and reverse 5¢-GTTGTAGCCAGTGTAGCAGAGAATAGC-3¢ located in the exon 3 were used to amplify a 209-bp fragment of the 140-kDa subunit of the RpII transcript. All amplified fragments were verified by sequencing. Reverse transcription products were used as templates for PCR reactions by using several dilutions to generate the corresponding standard curves. SYBR Green PCR Master Mix (Applied Biosystems, Madrid, Spain) was used according to manufacturer's instructions. The amplification was carried out in an ABI PRISM 7000 sequence detector using the following conditions: 2 min at 50°C, 10 min at 95°C, 40 cycles (15 s, 95°C; 30 s, 54°C; 30 s, 68°C) and using the dissociation curve protocol. To calculate the relative index of gene expression, we used the efficiency calibrated mathematical method as previously described (Marin et al., 2004) .
Northern blotting and in situ hybridization
Twenty-five micrograms of total RNA extracts (TRIZOL reagent) of each developmental stage were loaded into 1.5% agarose-formaldehyde gels and transferred to a nylon membrane (GE Healthcare Bioscience, Madrid, Spain). frq1-and frq2-specific probes were created by PCR using the following specific primers: forward primer 5¢-TACCAGATGGTGGGACAG-3¢ overlapping exons 7 and 8 of the frq1 gene and reverse primer 5¢-TTTGTTTAAGCGGGTTTC-3¢ in the 3¢UTR region of exon 8 of the frq1 gene. Similarly, forward primer 5¢-CGAACTGAGACCTATTTGG-3¢ in the 5¢UTR region of exon 2 of frq2 and the reverse primer 5¢-TCCTTTTCAGTGAAGTATGTG-3¢ overlapping exon 2 and exon 3 were used to synthesize the frq2 probe. The amplified products, 304 and 244 bp for frq1 and frq2 transcripts, respectively, were cloned into a pGEM-T-easy vector and verified by sequencing. Twenty-five to fifty nanograms of the Not-I liberated fragment of these constructs were [c- 32 P] dCTP radiolabelled using Ready-To-Go Labeling Beads (Amersham Biosciences, England) and used as probes at high stringency. Transcript sizes were estimated using a 0.24-9.5 kb RNA Ladder (Invitrogen, Barcelona, Spain). Whole-mount of CS embryos and in situ hybridization procedures were carried out as described previously (Ruiz Gomez & Bate, 1997) . Linearized pGEM-T vector with the 304-or 244-bp fragments of the frq1 or frq2 transcripts previously cloned (as described above) were used as templates for the digoxigenin-RNA labelling of the sense and antisenses probes according to the instructions of the supplier (Roche, Germany).
Sequence analyses
These were based on the EMBL ⁄ GENEBANK ⁄ DDBJ databases and carried out using the BLAST program of the NCBI and EMBL. The Genebank Fig. numbers which correspond to the aa sequences for FRQ ⁄ NCS-1 family members which have been analysed for several different species are as follows: Drosphila melanogaster P37236 and NP_996502 for Frq1 and Frq2, respectively; Danio rerio AAH55168 for NCS-1a; Danio rerio AAU04982 for NCS-1b; Rattus norvegicus NP_077342 for NCS-1; Mus musculus Q8BNY6 for NCS-1; Saccharomyces cerevisiae Q06389 for NCS-1; Homo sapiens AAH04856 for NCS-1; Xenopus laevis AAC59690 for FRQ. For sequence alignments we used the ClustalX (1.83) program. Genome analyses of different Drosophila species were carried out using the ECR browser webbased tool (Ovcharenko et al., 2004) .
Immunohistochemistry
Dissected larvae were fixed in 3.5% formaldehyde for 30 min. The fixed specimens were washed in phosphate-buffered saline containing 0.2% Triton X-100 (PBT) every 15 min for 1 h. The fixed and washed preparations were then incubated in the blocking solution [5% goat serum and BSA (1 g ⁄ 50 mL) in PBT] for 30 min. The preparations were incubated overnight at 4°C with FITC-conjugated antihorseradish peroxidase (HRP) antibody (1 : 100 dilution) or rabbit anti-HRP (1 : 200 dilution; Jackson ImmunoResearch, USA) to visualize neurons. To visualize active zones, we used the mouse monoclonal NC82 antibody (1 : 10 dilution), a generous gift from Erich Buchner (University of Würzburg, Germany) and Alois Hofbauer (University of Regensburg, Germany). The next day, the preparations were washed in PBT every 15 min for 1 h. They were incubated with the secondary antibody (Alexa Fluor 594 goat antimouse, Alexa Fluor 568 goat antirabbit or Alexa fluor 488 goat antimouse) in PBT for 2 h at room temperature, followed by washing in PBT every 15 min for 1 h. Finally, the preparations were mounted in a drop of Permafluor (Immunon, Pittsburgh, PA, USA) on a glass slide. Mounted preparations were viewed under a Leica TCS LS confocal laser-scanning microscope (Heidelberg, Germany) with 63· or 100· oil-immersion lenses.
Synapse and neuromuscular junction (NMJ) size quantification
Images (100·; 512 · 512 pixels) were taken of NMJs of larval muscles 6 and 7 on the third abdominal segment. Prior to morphological evaluation of axon terminals, the size of the muscle fibre was measured to ensure homogeneity between the NMJ finally considered in each genotype. This precautionary test was required to discard possible effects on NMJ size due to muscle fibre size. Motor neurons were analysed in 1-lm serial confocal sections using ImageJ software (National Institute of Health). Active zones were visualized as NC82-positive spots. This monoclonal antibody recognizes a Drosophila protein homolog to the mammalian CAST (Wagh et al., 2006) , and has been used in several studies as an active zone-specific marker (Laissue et al., 1999; Wucherpfennig et al., 2003; Bao et al., 2005; Guo et al., 2005; Qin et al., 2005; Martin-Pena et al., 2006) . Total NMJ planar surface was calculated on the basis of pixel size and number for the anti-HRP-positive signal. One NMJ was studied per larva and 8-12 larvae were examined per genotype. All numerical data are presented as average ± SEM. Statistical significance was calculated using Student's two-tailed t-test (unpaired two samples for means) after application of the Kolmogorov-Smirnov method to verify the normality of distribution of data. Differences were considered significant at P < 0.05.
Electrophysiology
Both whole-cell recordings and extracellular focal recordings were made from ventral longitudinal muscle fibre 6 (abdominal segment 3) in haemolymph-like solution HL6 (Macleod et al., 2002) . Electrical signals were recorded using the MacLab ⁄ 4S data acquisition system (AD Instruments, Sydney, Australia). Whole-cell recordings were performed on dissected larvae to determine spontaneously occurring miniature excitatory junction potentials (mEJP) and stimulus-evoked excitatory junction potentials (EJP) as described elsewhere (Cheung et al., 1999) . Sharp glass electrodes filled with 3 m KCl ( 40-60 MW) were used to impale the muscle fibre. Cut segmental nerves were stimulated at 2 Hz using a suction electrode. Extracellular focal recordings were obtained as previously described (Karunanithi et al., 1999) . Individual 1b and 1s boutons of motor neurons MN6 ⁄ 7-1b and MNSNb ⁄ d-1s, respectively (Hoang & Chiba, 2001 ) were identified using a 40· water-immersion lens and Nomarski optics. Focal macropatch electrodes with tips of 5 lm (inside diameter) were used for 1b boutons and electrodes with tips of 2-3 lm (inside diameter) were used for 1s boutons. These electrodes enclosed single 1b and 1s boutons, respectively. Signals for focal recordings were amplified using the Axoclamp-2A amplifier (Axon Instruments, Foster City, CA, USA). Quantal content was calculated for individual boutons by measuring the amplitude of their stimulus-evoked excitatory junction currents (EJC) and dividing that by the mean amplitude of their spontaneous miniature excitatory junction currents (mEJC). One bouton was recorded per larva.
Synthesis of dominant negative peptides
Drosophila Frq1 peptides (nontagged and tagged with a fluorophore) were synthesized at the Advanced Protein Technology Centre, Peptide Synthesis Facility (Toronto, Ontario, Canada). The Drosophila Frq1 C-terminal peptide (DKNHDGKLTLEEFREGSKADPRIVQALSL-GGG) was purified by HPLC. Tagged Frq1 C-terminal peptides had an Alexa Fluor 594 C5 maleimide conjugated to the N-terminus. A Drosophila scrambled Frq1 C-terminal peptide (DIDGDGQVN-GEEFRGTLASLSKLHKGLKAPER), similar to the mammalian NCS-1 scrambled peptide (Tsujimoto et al., 2002) , was also synthesized and used as a control.
Loading peptides into motor neurons
Motor neurons were forward-filled with peptides through cut axons (Macleod et al., 2002) . Briefly, the segmental nerve was cut and drawn into a glass suction electrode of inner diameter 12 lm. Within 5 min of cutting the segmental nerve, the peptide was delivered to the cut end of the nerve using a fine plastic tube. Texas Red was also forwardfilled with all peptides except the fluorescently tagged Frq1 C-terminal peptide. This allowed us to later confirm successful loading of synaptic boutons using confocal microscopy. Forward-filling of the fluorescent Frq1 C-terminal peptide provided an additional check on the entry of the introduced peptide into synaptic boutons. After 40 min, the peptide solution was replaced with HL6. Extracellular recordings were made on single 1b boutons 2 h after the segmental nerve was cut.
Buridan's paradigm
Three-to five-day-old females with clipped wings were left undisturbed to recover for 3 h within individual capsules with access to water. After this time, flies were transferred to the Buridan arena (Gotz, 1980) , where they walk spontaneously between two inaccessible landmarks (vertical black stripes) in an otherwise uniformly illuminated white surround. The movement of flies is recorded by a video camera for 1-5 min and analysed using the Buridan data evaluation software kindly provided by Dr R. Wolf (Theodor-Boveri Institute, Würzburg, Germany). The Kolmogorov-Smirnov test for normality was always performed before application of Student's t-test for statistical significance. Differences were considered significant at P < 0.05.
Results
Frq is represented by two highly conserved genes in Drosophila. The genomic region corresponding to the 16F to 17A polytene chromosome bands has been the subject of a systematic genetic and molecular analysis (Prado et al., 1999) . A comparison of frq mRNA and genomic sequences revealed a second gene encoding a protein 94.7% identical to the previously reported Frq (Pongs et al., 1993) . The new gene corresponds to transcription unit CG5907 while the previously reported one corresponds to CG5744 in the Drosophila genome database (http://flybase.bio.indiana.edu/). We named the two genes frq2 and frq1, respectively. They have a similar intron-exon structure, are spaced 11.6 kb apart, and their corresponding chromosome bands are 17A1 for frq1 and 17A2 for frq2. Also, the breakpoint of the chromosomal rearrangement T(X;Y)V7 serves as a landmark to separate them (Fig. 1A) . A third, unrelated, gene, Andorra (and), is located between the two frq genes. Similar to frq1, the longest ORF in frq2 predicts a 187-aa protein of 22 kDa. The two sequences, however, turned out to be nonidentical. Frq2 differs in 10 residues from Frq1 (Fig. 1B) . Both proteins conserve the characteristic four EF-hand Ca 2+ -binding domains. Changes S > A at position 79 and K > R at 163 correspond to -y sites involved in Ca 2+ coordination of the 2nd and 4th EF hands (Strynadka & James, 1989) . However, the 2nd EF-hand motif of Frq1 is nonfunctional (Pongs et al., 1993) . At the N-terminus, the consensus myristoylation domain MGXXXS ⁄ T(K) (Towler et al., 1988 ) is preserved in both Frqs, albeit with a noncritical change, N > S, at position 5 in Frq1. The remaining seven aa differences do not correspond to obvious protein domains. Overall, the nature and position of the 10-aa differences suggest that the two Frqs would perform very similar functions with a possible difference in the efficiency of Ca 2+ -binding by the 4th EFhand motif. While we found two frq genes in all the Drosophila species analysed, no duplicated frq genes have been found in yeast, other invertebrate and most vertebrate genomes. The only exception is the zebra fish (Danio rerio) where an equivalent, highly conserved, duplication is found (Fig. 1B) . To gain insight into this exceptional case of sequence conservation (see Discussion), we conducted a comparative analysis of the two Frqs in Drosophila.
Frequenin expression profiles show quantitative, but not qualitative, differences. Using specific probes for each frq transcript, we carried out developmental Northern blot assays ( Fig. 2A) . frq1 mRNA with a size of 6 kb was detected in embryos, first instar larvae and adult stages. The observations confirm the previous size and expression pattern described for frq1 mRNA (Pongs et al., 1993) . By contrast, frq2 mRNA was clearly detectable at first instar larvae and adult stages but with a smaller size, 4.4 kb ( Fig. 2A) . In addition, QRT-PCR assays were used to quantify the relative levels of each frq mRNA during development (Fig. 2B) . While frq1 mRNA is two-to three-fold more abundant at the end of the embryo stage and in first instar larvae than in the adult, frq2 mRNA during development never reaches adult levels (Fig. 2B, left panel) . Comparing mRNA expression in the adult, frq1 shows a 20-30% higher level than frq2 (Fig. 2B, right panel) . The in situ expression pattern was determined by whole-mount hybridization in 16-to 20-h-old embryos (stage 17). Significant expression in the ventral ganglia was found for both genes, and this expression appears specific (Fig. 2C) . Thus, the temporal and spatial expression profiles of the two frqs are very similar but their quantitative levels differ.
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Genetic tools modified Frq-specific expression or function The chromosomal rearrangement T(X;Y)V7 was previously described as an overexpresser of frq (Pongs et al., 1993) . In order to clarify which of the two genes is affected by this rearrangement, we measured the relative expression of each gene in adult V7 males (Fig. 3A) . The results show a two-to three-fold increase for frq2 but not for frq1. This observation demonstrates that transcription is independently regulated in each frq gene. Also, the specificity of the effect is compatible with the location of the V7 breakpoint, 3¢ to frq1 and 11.6 kb away from the 5¢ of frq2 (Fig. 1A) .
To obtain specific overexpression of each Frq, we cloned two fragments of 709 and 750 bp containing the ORFs of frq1 and frq2 separately into pUASt vectors (see Materials and Methods). The strong sequence similarity between the two frq genes, in addition to their close proximity, albeit with a small unrelated gene, Andorra, in between, made it technically unfeasible to produce clean deficiencies binding EF-hand (black lines I-IV) and myristoylation (stripped box) motifs are indicated. Ca 2+ coordinating residues (x, y, z, -x, -y and -z) are also indicated in each EF-hand motif. Differential aas are boxed. *P < 0.05 or better.
for these genes. Indeed, attempts to elicit homologous recombination (Rong & Golic, 2000) failed in this case. Thus, to obtain reduced gene expression, we designed an RNAi construct (Kalidas & Smith, 2002;  supplementary Fig. S1 ). Several transgenic lines were obtained for each construct, mapped and referred to as UAS-frq1, UAS-frq2 and UAS-RNAi. The transcriptional effects of each construct were measured using QRT-PCR assays (Fig. 3B) . Line 64C appeared to be the strongest frq1 overexpresser while line 14A was the best for frq2. Among the RNAi constructs, the two available lines were similarly efficient for both frq genes.
Thus, RNAi caused gene attenuation and the lines obtained represent hypomorphic alleles. Reasonably, the transcriptional effects of RNAi on frq genes would be expected to be quite similar in all cell types. However, as an additional approach to loss-of-function studies, we used the transgenic expression of a C-terminal peptide which has been used as a dominant negative for the endogenous mammalian protein (Tsujimoto et al., 2002) . This type of experiment is, in effect, a method of inactivating the native Frq targets. We generated transgenic lines carrying the constructs UAS-DN-Frq1 and UAS-DN-Frq2 that express the Drosophila Frq1 or Frq2 sequences homologous to the mammalian DN peptide. The effectiveness of the DN peptides was evaluated by observing the resulting phenotypes and comparing them with controls and over-expressers. Finally, the most extreme condition was obtained by coexpressing RNAi and DN constructs. All these genetic tools were used, alone or in combination, for structural and functional studies.
Effects of Frq on axonal boutons and synapses
A previous study found that overexpression of Frq reduced the number of synaptic boutons innervating the larval ventral longitudinal muscles fibers 12 and 13 (Angaut-Petit et al., 1998). However, this study did not differentiate between type I and type II innervation, nor between type 1s and type 1b boutons (Hoang & Chiba, 2001) . To obtain a more specific picture of the effects of altered Frq expression or function, we performed a detailed analysis of NMJs from muscle fibres 6-7 of abdominal segment 3, which are innervated by type 1b and type 1s boutons. Type 1b boutons are larger on average than type 1s boutons, and the two types are produced by different motor axons. Type 1s motor neurons (two per hemisegment) each innervate many muscle fibres and act as 'common excitors', whereas type 1b motor neurons ( 30 per hemisegment) each synapse with one muscle fibre or a pair, and provide specific control of their target muscle fibres. The motor impulse output of type 1b motor neurons is more regular and sustained than that of type 1s motor neurons (Kurdyak et al., 1994) . To this end, we costained fixed third instar larvae with anti-HRP (as neuronal membrane marker) and NC82 monoclonal antibody (as active zone marker; Kittel et al., 2006a,b; Wagh et al., 2006) . Confocal microscopy allowed us to discriminate between 1b and 1s boutons. There was a strong reduction in the number of boutons in Frq1 and Frq2 overexpressers, while there was an increase in the number of boutons in loss-of-function genotypes (Fig. 4A, C  and D) . In both cases, the effects were specific for type 1s boutons ( Fig. 4A and C) . In addition, the total NMJ surface was reduced in Frq overexpressers and increased in genotypes expressing the dominant negative form. The magnitude of the effect, however, was rather weak in both cases although more robust for Frq1 than for Frq2 (Fig. 4A and  B) . No changes in bouton diameter were detected for controls, Frq1 overexpressers or DN-Frq1 ⁄ DN-Frq2 ⁄ RNAi expressers. The reduction in number of small type 1s boutons suggests a specific effect of Frq on MNSNb ⁄ d-Is development.
To explore whether changes in axonal surface are accompanied by variations in synapse number, we counted total number of active zones, as NC82-positive spots, and found a significant reduction in Frq overexpressers in comparison to the controls (Fig. 4A and B) . As no effect was detected in the loss-of-function genotypes, the reduction in active zones number in overexpressers was probably an indirect consequence of the reduced MNSNb ⁄ d-Is growth of the NMJ caused by the excess of Frq. Axonal growth and synaptogenesis are independent processes (Martin-Pena et al., 2006) .
Effects of Frq on synaptic transmission
Whole-cell intracellular recordings of the compound EJP generated by type 1b and type 1s boutons were obtained from muscle 6 of third instar larvae (Fig. 5) . As in the morphological study, D42-Gal4 or elav-Gal4 were used to drive the expression of UAS constructs. In HL3 bath solution , we found no significant differences between CS(+) and all parental lines (data not shown). In HL3 (1 mm Ca 2+ data not shown) and HL6 (1 mm Ca 2+ ) solutions , nerve-evoked EJPs recorded from Frq1, Frq2 and Frq1 ⁄ Frq2 overexpressers were significantly larger than for controls. By contrast, loss-of-function genotypes exhibited a significant decrease in the amplitude of nerve-evoked EJPs (Fig. 5A and B) . We did not observe the previously described enhanced facilitation phenotype of Frq overexpressers (Mallart et al., 1991; Pongs et al., 1993; Rivosecchi et al., 1994) in HL6 at 1 mm Ca 2+ . Spontaneous release was not affected in frequency or amplitude in any of the genotypes analysed ( Fig. 5C and D) . As observed for the other morphological and functional traits, the RNAi genotypes failed to show significant differences vs. controls. This indicates that the residual Frq levels caused by this gene attenuation method were still sufficient for normal structure and physiology, at least under laboratory rearing conditions. It can be concluded that basal evoked, but not spontaneous, release was dependent on Frq levels and ⁄ or presynaptic activity of Frq.
Frq regulated quantal release per bouton
Why are EJPs larger in Frq overexpressers despite a reduction in the number of synaptic boutons, and the opposite in Frq loss-of-function genotypes? A possible explanation is that Frq overexpressers release more transmitter per bouton than controls, whereas loss-of-function genotypes release less. To test this hypothesis, we used extracellular macropatch electrodes to record and assess synaptic transmission from single boutons . Type 1b and 1s boutons were identified using Nomarski optics; single boutons at the end of nerve terminals were selected for recordings. The segmental nerve was stimulated at 2 Hz while the preparation was maintained in HL6 (1 mm Ca 2+ ). Overexpression of Frq1, Frq2 or both caused an almost two-fold increase in quantal content (quanta released per stimulus) for single 1b boutons (Fig. 6 ). For the same genotypes, there was an In all cases, the indicated construct is driven by tub-Gal4-LL7. Values are normalized for the control genotype (tub-Gal4-LL7). Note the specificity of excess-of-function constructs for each UAS-Frq line, while the UAS-RNAi constructs attenuate expression of both frqs. The effects are consistent among several transgenic lines. Genotypes: Control, + ⁄ tub-Gal4-LL7; Frq1-49B, UAS-Frq1-49B ⁄ tub-Gal4-LL7; Frq1-62 A, UAS-Frq1-62 A ⁄ tub-Gal4-LL7; Frq1-64C, UAS-Frq1-64C ⁄ tub-Gal4-LL7; Frq2-8 A, UAS-Frq2-8 A ⁄ tub-Gal4-LL7; Frq2-14A, UAS-Frq2-14A ⁄ tub-Gal4-LL7; Frq2-33C, UAS-Frq2-33C ⁄ tub-Gal4-LL7; RNAi-51B, UAS-RNAi-51B ⁄ tubGal4-LL7; RNAi-33C, UAS-RNAi-33C ⁄ tub-Gal4-LL7.
1.4-fold increase in quantal content for single 1s boutons (Fig. 7 ). There were no significant differences between RNAi genotypes and controls, but a significant reduction in quantal content was observed in loss-of-function genotypes which coexpress RNAi and DN constructs, in agreement with intracellular recordings. The amplitude and frequency of spontaneously occurring quantal events of 1b and 1s boutons showed no significant differences between genotypes (data not shown). Thus, the larger EJPs of Frq overexpressers can be attributed to enhanced release of transmitter at individual 1b and 1s boutons, while the smaller EJPs observed in loss-of-function genotypes resulted from decreased release of transmitter from these boutons.
Frq regulated release per synapse
In previous comparative studies, the number of active zones and synapses has sometimes been correlated with quantal release properties . Therefore, the effects of Frq may be due to changes in the number of active zones per bouton. This was tested by counting the number of NC82 spots from a sample of 1b ( 5 lm in diameter) and 1s ( 2 lm in diameter) boutons. We compared the number of active zones of selected boutons in the excess and loss-of-function genotypes. As with focal recordings, boutons were selected at the end of strings.
The number of synapses with active zones in control boutons based on NC82 spots (Fig. 8A and B ) was similar to previously reported electron microscopy data (1b bouton, 41 active zones; 1s boutons, seven active zones; Atwood et al., 1993) . No differences in the number of active zones per bouton (1b or 1s) were observed in Frq1 overexpressers, Frq2 overexpressers or Frq1,2 underexpressers (1b boutons: 33.4 ± 5.6 in wild type (+), 35.54 ± 3.4 in Frq1-64C, 39.25 ± 3.9 in Frq2-14A and 28.70 ± 3.58 in RNAi-51B; 1s boutons: 11.67 ± 3.68 in +, 11.61 ± 2.3 in Frq1-64C, 11.25 ± 2.48 in Frq2-14A and 9.80 ± 1.83 in RNAi-51B; Fig. 8B ). DN-Frq1 peptide expressed in elav-Gal4 ⁄ RNAi lines showed no significant changes , and total NC82-positive spots as indicative of active zone number (grey histograms, right Y axis) of various genotypes (D42 and elav-Gal4 drivers for UAS constructs; n ¼ 7-9 larvae per genotype, *P < 0.05). Error bars represent SEM. (C) Number of boutons from muscles 6 and 7 on segment 3. Type 1s boutons were decreased in Frq overexpressers (stippled bars; P < 0.01, n ¼ 6). Loss-of-function due to the coexpression of RNAi and dominant negative peptide caused an increase in the number of the same bouton type. Error bars represent SD. Note that the three control genotypes (+, D42-Gal4 and elav-Gal4) yielded very similar values. Genotypes: +, CS; D42-Gal4, + ⁄ D42-Gal4; elav-Gal4,
Scale bar in A, 40 lm. *P < 0.05 or better.
vs. their parental control. However, when both DN-Frq peptides were expressed in the same elav-Gal4 ⁄ RNAi background, a significant decrease in the number of active zones per bouton was measured (1b boutons: 23.87 ± 5 in elav-Gal4, 20.74 ± 4.2 in elav-Gal4 ⁄ RNAi ⁄ DN-Frq1, 15.69 ± 3.84 in elav-Gal4 ⁄ RNAi ⁄ DN-Frq1 ⁄ Dn-Frq2; 1s boutons: 11.77 ± 3.75 in elav-Gal4, 11.25 ± 2.62 in elav-Gal4 ⁄ RNAi ⁄ DN-Frq1, 7.89 ± 2.54 in elavGal4 ⁄ RNAi ⁄ DN-Frq1 ⁄ Dn-Frq2). We calculated the mean quantal emission per active zone by dividing quantal release from a single bouton by the number of NC82-stained active zones in boutons of corresponding size and location (i.e. boutons at the end of a string). Transgenic or mutant lines overexpressing Frq1 or Frq2 showed enhanced release per active zone in 1b and 1s boutons with respect to controls, while the inactivation of Frq function drastically decreased release per active zone in both types of bouton (Fig. 8C) .
Interestingly, in this study (Figs 6 and 7) and in a previous study (Karunanithi et al., 1997) , 1b and 1s boutons were observed to release almost the same number of quanta at low frequency stimulation (1 Hz in Karunanithi et al., 1997 ; 2 Hz in this study), despite the smaller size of 1s boutons; 1b boutons are 3-5 lm in diameter whereas 1s boutons are 1-3 lm in diameter and have fewer active zones (Atwood et al., 1993) . When we calculated quantal emission per active zone for control boutons, it was clear that 1s boutons were able to release similar numbers of quanta per stimulus despite being smaller than 1b boutons, because 1s boutons have greater transmission at individual active zones (Fig. 8C) . 
Acute disruption of Frq
The physiological loss-of-function phenotypes described above could be due to a developmental effect or homeostatic compensation for the observed morphological phenotypes (increase in the number of boutons and a reduction in the number of active zones per bouton).
To determine whether Frq was having a direct effect on neurotransmitter release, we acutely disrupted the effects of Frq by forward-filling motor neurons of Frq underexpressers with 50 lm of a C-terminal peptide to the Drosophila Frq1 sequence and found a 70% reduction in quantal content at single 1b boutons (Fig. 9) . It is likely that the peptide 2+ caused a 1.8-to 2.6-fold increase in Frq overexpressers. By contrast, loss-of-function lines (RNAi ⁄ DN peptide combinations) showed a three-fold decrease in release from single 1b boutons in comparison to controls (P < 0.01, n ¼ 8-12). Error bars represent SD. Genotypes: 2+ shows a 1.5-to 1.9-fold release increase from single 1s boutons of Frq overexpressers and the opposite effect in loss-of-function genotypes. (P < 0.01, n ¼ 6-12). Error bars represent SD. Genotypes: +, CS; D42-Gal4 ¼+ ⁄ D42-Gal4; D42 ⁄ Frq1-49B, UAS-Frq1-49B ⁄ D42-Gal4; V7,
interferes with the actions of both Frqs because the aa sequences of the two C-terminals differ by only three out of 32 aa. The reduction in quantal content we observed in the forward-filling experiments was similar to that observed in larvae chronically expressing the transgenic Drosophila C-terminal peptide (Fig. 6) . In some experiments we included 10 mm Texas Red with the peptide to confirm that the loading procedure was successful. Reductions in transmitter release occurred both in the presence and in the absence of Texas Red. In addition, we loaded fluorescently tagged C-terminal peptide into the terminals, confirming its presence by fluorescence microscopy (Fig. 9A) , and found that transmitter release was strongly reduced (Fig. 9C) . No effect was observed when either 10 mm Texas Red or 50 lm of Drosophila scrambled C-terminal peptide with 10 mm Texas Red was forwardfilled into boutons of Frq underexpressers (Fig. 9B and C) . The acute introduction of the C-terminal peptide demonstrated that Frq had a direct effect on basal levels of neurotransmitter release, independent of its effects on synaptic bouton and synapse formation.
Effects of Frq on behaviour
The morphological and functional effects described for the larval NMJ woud be expected to be general throughout the nervous system. However, the magnitude of the synaptic changes observed raises the question: will they be strong enough to result in behavioural changes? The question is particularly relevant considering the unusual sequence conservation of the two frq genes, which indicates that no feature variations would be available for selection during evolution. We carried out routine screenings by observing standard behaviours in the adult: grooming, jumping, flight, courtship, fertility, geo-and phototaxia; and in the larvae: touch reflex, carving down for food and crawling up for pupation. None of these activities showed overt qualitative differences in either loss-or excess-of-function genotypes with respect to the wild type. Therefore, we quantified adult locomotion in Buridan's arena. This test, developed by Gotz (1980) , has been used in other studies as a detailed description of the locomotor behaviour in flies (Strauss & Heisenberg, 1993; Strauss & Pichler, 1998) . Our data show a significant reduction in walking speed when the DN peptides for either Frq were expressed in the nervous system using elav-GAL4 line as driver (Fig. 10) . Perhaps as an indirect consequence of this effect, the average distance walked was also reduced in these animals (Fig. 10) . These data suggest that the synaptic effects observed in the larval NMJ probably also occur in the adult, and demonstrate that their magnitude is large enough to produce changes in behaviour. It is also likely that quantitative changes will be found in other behaviours if suitable tests are applied.
Discussion
Here, we report the discovery of a nondivergent duplicated gene whose expression profile and phenotypic traits were analysed along with those of the original frq gene. Our results indicate that frq1 and frq2 have similar expression patterns and synaptic functions. The apparent functional redundancy and sequence conservation of these genes greatly constrains the design of tools for experimental studies. 
. Scale bar in A, 4 lm. *P < 0.05 or better.
The dominant negative peptide approach has been successfully used in other cases, including experiments on the single mammalian Frq protein (Tsujimoto et al., 2002) , when genetic deficiencies have not been available. In several other Drosophila studies, similar phenotypes have been observed in null mutants and in lines expressing a dominant negative transgene (Stewart et al., 2005) . More generally, the two approaches have produced similar effects even in different species, as in the case of the role of Hsc70 in exocytosis (Bronk et al., 2001; Morgan et al., 2001) . In the present study, target inactivation by a dominant negative peptide shows that neurotransmitter release is strongly reduced, either through transgenic expression or by acute loading of the peptide into motor axons. Testing less severe loss-offunction conditions, equivalent to classical hypomorph alleles, was required to detect possible dosage effects of the two Frqs, either singly or in combination. We found that neurotransmitter release was strongly influenced by Frqs although, as is often the case with many other synaptic products, relatively low levels of these proteins achieved with RNAi techniques are still able to support normal function. It is worth pointing out that maternal deposition of Frqs cannot be invoked as an additional supply in underexpressers because the wild-type oocytes show no trace of this putative deposition (Fig. 2B) . 
Frq2, elav-Gal4 ⁄ UAS-Frq2-33C. *P < 0.05 or better.
Two Frq genes
The duplication of Frqs with unprecedentedly low sequence divergence in Drosophila prompted a search for the same phenomenon in other species. No duplicated frq genes were found in Saccharomyces cerevisiae, Caenorhabditis elegans, Apis melifera or Anopheles gambiae, or in several vertebrate genomes: Homo sapiens, Mus musculus, Rattus norvergicus and Xenopus laevis. The only vertebrate exception is the zebrafish Danio rerio in which the cloning and characterization of NCS-1a and NCS-1b have recently been described (Blasiole et al., 2005) . The two Danio Frq proteins have diverged by only 7 aa (Fig. 1B) ; this is similar to the situation in Drosophila. The high conservation of Frq sequences is also maintained among species with only one Frq gene. For instance, there is no divergence between Rattus, Mus and Homo, and only 1 aa separates Xenopus from Homo. Even between vertebrates and invertebrates, the sequence identity reaches the unusually high average value of 75%. Several cases of low sequence divergence are known and interpreted as proteins with strong functional constraints or tissue-temporal specificity of expression (Matzkin, 2005; Wallis et al., 2005) . When genes are duplicated, however, the general trend is towards rapid divergence or degradation to pseudogene status given the functional redundancy (Rodin et al., 2005) . The strong sequence conservation between D. melanogaster and D. mojavensis and the lack of evidence of frq gene duplication in most other species is unusual, as is the lack of sequence divergence between Mus, Rattus and Homo. It is likely that the multiplicity of functional interactions that involve Frq ⁄ NCS-1 (Zucker, 2003; Burgoyne et al., 2004) could represent the required evolutionary constraint which would account for this unusual sequence conservation.
Here, we addressed whether the two Drosophila frq genes have different roles or whether they together perform the function of the single mammalian NCS-1 in the synapse. We found that the temporal and spatial expression patterns of Frq1 and Frq2 were very similar. However, Frq1 was expressed at higher levels than Frq2 throughout development. Interestingly, Frq1 was present at higher levels at the end of the embryonic stage and in first instar larvae in comparison to adults. Besides the 10-aa sequence divergence, this quantitative expression difference was the only distinguishing feature between the two Frqs, in both Drosophila and Danio. It should also be noted that, despite the low levels of Frq mRNA detected in third instar larvae, anti-Frq antibodies stain the CNS and PNS in Drosophila embryonic, larval and adult tissue sections, indicating strong protein expression at all stages (Pongs et al., 1993) . Frq was shown to be present in synaptic boutons of third instar larvae; however, this antibody probably recognized both Frq1 and Frq2, as the two proteins are highly homologous.
Two separate effects of Frq
Overexpressers exhibit enhanced neurotransmission and reduced muscle innervation, while expression of the dominant negative peptide caused a large reduction in neurotransmitter release and an increase in bouton numbers. The question arises: are the effects on neurotransmitter release and nerve terminal growth interrelated, perhaps through mechanisms known to effect homeostatic regulation at the NMJ (Stewart et al., 1996; Davis & Goodman, 1998) ? The present data clearly indicate that the two effects are not tightly linked. First, effects on terminal growth were limited to only one of the two glutamatergic motor neurons innervating muscles 6 and 7, while effects on transmitter release were seen in both neurons. Second, chronic expression of the dominant negative peptide affected both terminal growth and transmitter release, while forward-filling the peptide produced a rapid reduction in transmitter release (similar in magnitude to that obtained with transgenic expression) but no effect on terminal morphology. The effects on transmitter release evidently occurred with or without changes in terminal morphology. Conversely, in type 1b terminals, gross morphological changes were not evident despite elevated transmitter release. If homeostatic feedback linking terminal growth to transmitter release occurs, it affects only one of the two motor neurons innervating the same muscle fibers. It might be argued that the altered terminal morphology in over-and underexpressers is a consequence of the changes in evoked transmitter release in the boutons. Although conceivable, this explanation seems unlikely given the selective morphological effects in type 1s motor neuron terminals. The most economical hypothesis in view of the two lines of available evidence is that the two effects of Frq are not tightly coupled. Both may contribute to altered synaptic function in the nervous system. In summary, the two synaptic effects of Frqs, on release and on axon growth, are cell-autonomous because the experimental modifications have been driven specifically to neurons. Also, these effects cannot be attributed to homeostatic regulation during development because they are reproduced under chronic as well as acute expression of DN peptides. By contrast, changes in the number of active zones are likely to be an indirect effect of axon terminal growth. This is in agreement with other reports that show independent mechanisms for axon growth and synaptogenesis (Martin-Pena et al., 2006) .
Enhancement and reduction in transmitter release
The observed effects of Frq on neurotransmission in Drosophila are primarily presynaptic and may involve more than one cellular mechanism. The present results clarify some previous observations on this point, and add new information. Overexpression resulted in similar increases of quantal release per bouton and per synapse. Therefore, Frq1 and Frq2 exhibit similar expression profiles and probably have similar functions in exocytosis, which is not surprising considering their 95% sequence identity.
Overexpression of Frq in Drosophila was previously reported to enhance facilitation in response to paired-pulse and high-frequency train stimulation, but not to affect spontaneous neurotransmitter release or evoked neurotransmitter release elicited by low-frequency stimulation ('basal release'; Mallart et al., 1991; Pongs et al., 1993; Rivosecchi et al., 1994) . In contrast, the injection of Frq into Xenopus embryonic spinal neurons caused an increase in both spontaneous and evoked neurotransmitter release, and decreased paired-pulse facilitation (Olafsson et al., 1995; Wang et al., 2001 ). An explanation for this difference may be the low Ca 2+ concentrations (0.12-0.2 mm) used in the previous Drosophila studies. We found that overexpression of Frq1 or Frq2 enhanced basal transmitter release at external Ca 2+ concentrations of 1 mm in the more haemolymph-like solutions (HL3 or HL6). The effects of Frq on neurotransmission evidently depend on the external Ca 2+ concentration, thus accounting for the discrepant findings reported previously. The difference in spontaneous release between Drosophila and Xenopus may be due to differences in the resting intraterminal Ca 2+ concentration or Ca 2+ sensitivity. Reduction of Frq by transgenic expression of RNAi had little effect on basal release, most likely because the remnant mRNA can still be translated into protein levels sufficient for near-normal transmitter release. Introduction of the dominant negative C-terminal peptide proved more effective, reducing quantal content of boutons to 1 ⁄ 3 normal. Thus, manipulations of the actions and levels of Frq can modulate quantal content over a six-fold range. Furthermore, in accord with previous results in C. elegans (Gomez et al., 2001) , the flies in which Frq was both underexpressed and inhibited were viable and apparently healthy, suggesting strongly that Frq is not required for viability, even though it is in yeast (Hendricks et al., 1999) .
Akin to the loss-of-function effects of Frq, Drosophila synaptotagmin 1 mutants drastically reduce evoked release (Broadie et al., 1994) . Synaptotagmin 1 is the best known Ca 2+ sensor regulating neurotransmitter release at synapses (Littleton et al., 2001; Yoshihara & Littleton, 2002) . We tested the possible functional redundancy between Frqs and Syt by asking whether over-or under-expression of Frqs could rescue sytAD4 lethality. The results were negative (data not shown), suggesting that the mechanisms of these two types of Ca 2+ -binding proteins are independent.
The effects of Frq on axon terminal structure
Frq influences the structural features of nerve terminals. Unlike other hyperexcitable Drosophila mutants (Shaker, ether-à -gogo, Hyperkinetic), Frq1 and Frq2 overexpressers showed a reduction in the number of synaptic boutons, specifically type 1s boutons. The opposite effect is obtained in Frq loss-of-function genotypes (Fig. 4C ). In agreement with these effects in Drosophila, the numbers of neurites per cell and branches per neurite, and the length of neurites were reduced in NG-108-15 cells transfected with NCS-1 (Chen et al., 2001) . Conversely, neuritogenesis was increased in human HEK293 cells transfected with dominant negative forms of NCS-1 in which the third EF hand is inactivated (Hui et al., 2006) . As discussed above, these morphological changes are probably not a direct consequence of enhanced transmitter release. Frq apparently has a developmental role in the regulation of terminal growth and synaptogenesis. NCS-1 has been implicated in synaptogenesis in the rat retina (Reynolds et al., 2001) and axon outgrowth in the chick retina (Bergmann et al., 2002) . Interestingly, in Drosophila the effect is strongly evident in only one of the two motor neurons innervating muscles 6 and 7: the more phasic neuron (Lnenicka & Keshishian, 2000) . Higher levels of Frq have been observed in crayfish phasic axons (Jeromin et al., 1999) and, more recently, in frog phasic motor neurons (Belair et al., 2005) . The differential effect of Frq may depend on its timing or amount of expression in different types of neurons. The opposite effects of Frq overexpression on neurotransmitter release (which is enhanced) and nerve terminal growth (which is reduced) requires further investigation. One possible explanation is that, in Drosophila, synapses may include more than one active zone T-bar (as seen with the electron microscope) within a single adhesion point or synapse (Stewart et al., 1996) . Synaptic vesicles are thought to dock and fuse preferentially at active zones (Feeney et al., 1998; Garner et al., 2000) . In conventional fluorescence microscopy, the NC82-positive spots cannot resolve multiple active zones at individual synapses. If the proportion of synapses with multiple active zones were larger in Frq overexpressers, even though the total number of synapses is less, the apparent conflict between the morphological and functional traits might be resolved. Alternatively, extra Frq may increase the entry of Ca 2+ (Wang et al., 2001) or the sensitivity of exocytotic machinery to Ca 2+ at individual active zones. Evidence for the role of Frq in regulating Ca 2+ channels has been shown by loading NCS-1 into nerve terminals of the calyx of Held, causing activitydependent facilitation of P ⁄ Q-type calcium currents; a presynaptically loaded interfering carboxyl-terminal peptide of NCS-1 abolished this facilitation (Tsujimoto et al., 2002) . At this point, we can conclude that Frqs, either as single or duplicated genes, modulate axon terminal morphology and neurotransmitter release through independent mechanisms.
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